Trial
NCT00657553
Preemptive Strike With Bortezomib in Multiple Myeloma Patients
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Arkansas
Collaborators
—
Condition
Multiple Myeloma
Intervention
Bortezomib
Why stopped
Due to poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-11-20